Transcriptomics

Dataset Information

Effects of a novel HBP inhibitor, FR054, and Gemcitabine in pancreatic cancer cells


ABSTRACT: In order to define the role of the Hexosamine Biosynthetic Pathaway (HBP) in pancreatic cancer cells proliferation, survival and gemcitabine resistance, we treated MiaPaCa2 and BxPC3 cells with FR054, a novel HBP inhbitor, and gemcitabine either alone or in combination for 48h

ORGANISM(S): Homo sapiens

PROVIDER: GSE223303 | GEO | 2023/05/08

REPOSITORIES: GEO